A61K33/12

RODENTICIDE BINDING SYSTEM
20180092354 · 2018-04-05 ·

In some embodiments, a composition and/or method may include a rodenticide binding system formulated for safe and effective mixture into various feed rations which are fed to monogastric and ruminant animals such as poultry, swine, cows, cattle, and fish, among others. The rodenticide binding system includes novel combinations of one or more of an organoclay, an activated hydrated sodium calcium aluminosilicate clay, and a synthetic hectorite clay. In some embodiments, the binding composition may include organoclay, bentonite, hectorite, Leonardite, and/or any combination thereof. The toxin binding complex may effectively bind some pesticides (e.g., rodenticides) in the animal's digestive system, preventing their absorption and the consequent damages to the animal.

RODENTICIDE BINDING SYSTEM
20180092354 · 2018-04-05 ·

In some embodiments, a composition and/or method may include a rodenticide binding system formulated for safe and effective mixture into various feed rations which are fed to monogastric and ruminant animals such as poultry, swine, cows, cattle, and fish, among others. The rodenticide binding system includes novel combinations of one or more of an organoclay, an activated hydrated sodium calcium aluminosilicate clay, and a synthetic hectorite clay. In some embodiments, the binding composition may include organoclay, bentonite, hectorite, Leonardite, and/or any combination thereof. The toxin binding complex may effectively bind some pesticides (e.g., rodenticides) in the animal's digestive system, preventing their absorption and the consequent damages to the animal.

Multi-Chambered Dispenser for the Topical Application of Infused Fluid
20180056012 · 2018-03-01 ·

A multi-chambered dispenser which both retains solid objects such as mineral and ceramic stones in a defined region and also enables fluid communication with the objects is provided. A permeable inner wall may be disposed within an outer chamber to define a barrier preventing the solid objects maintained within the outer chamber from entering an inner chamber defined by the permeable inner wall. Fluid, such as tap or even filtered water, may be poured into the dispenser, and, owing to the permeation of the inner wall, freely communicate with the objects maintained outside of the permeable inner wall to absorb and become infused with various beneficial characteristics comprising the objects. Means for dispensing the infused fluid for topical application may be configured to draw infused fluid out of the dispenser through the inner chamber such that interference of such means by the solid objects is avoided.

Multi-Chambered Dispenser for the Topical Application of Infused Fluid
20180056012 · 2018-03-01 ·

A multi-chambered dispenser which both retains solid objects such as mineral and ceramic stones in a defined region and also enables fluid communication with the objects is provided. A permeable inner wall may be disposed within an outer chamber to define a barrier preventing the solid objects maintained within the outer chamber from entering an inner chamber defined by the permeable inner wall. Fluid, such as tap or even filtered water, may be poured into the dispenser, and, owing to the permeation of the inner wall, freely communicate with the objects maintained outside of the permeable inner wall to absorb and become infused with various beneficial characteristics comprising the objects. Means for dispensing the infused fluid for topical application may be configured to draw infused fluid out of the dispenser through the inner chamber such that interference of such means by the solid objects is avoided.

METHOD OF PRODUCING A EXTRUDED COMPOSITION

The present invention relates to a method of producing a direct compression tablet composition comprising the step of processing ibuprofen, a hydrophilic polymer, and an inorganic excipient by an extrusion process to produce an extruded composition in which the ibuprofen forms a solid dispersion/solution within the hydrophilic polymer. The invention is particularly useful in preparing oral dissolvable tablets. Also provided are composition comprising an inorganic excipient and ibuprofen within a hydrophilic polymer.

METHOD OF PRODUCING A EXTRUDED COMPOSITION

The present invention relates to a method of producing a direct compression tablet composition comprising the step of processing ibuprofen, a hydrophilic polymer, and an inorganic excipient by an extrusion process to produce an extruded composition in which the ibuprofen forms a solid dispersion/solution within the hydrophilic polymer. The invention is particularly useful in preparing oral dissolvable tablets. Also provided are composition comprising an inorganic excipient and ibuprofen within a hydrophilic polymer.

Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.

Methods of treating or ameliorating skin conditions with a magnetic dipole stabilized solution

The present invention is directed to methods for treating or ameliorating skin conditions, diabetic conditions, cardiovascular conditions, cancer, infections or metal poisoning, enhancing performance, or providing nutritional support, comprising administering to a subject in need thereof compositions comprising a magnetic dipole stabilized solution (MDSS). The MDSS solution may include additional components and can be provided in a kit.

Lipid emulsion for parenteral nutrition comprising GPC

The present disclosure relates to parenteral nutritional formulations, including ready-to-use parenteral nutrition formulations. More particularly, the present disclosure is directed to lipid formulations or emulsions and multi-chamber containers comprising same, wherein the lipid emulsion contains glycerophosphorylcholine as a choline source. The present disclosure further relates to methods of providing choline to a patient in need of parenteral nutrition and methods of avoiding and/or treating choline deficiency and liver damage.

Film coated tablet containing choline alfoscerate and process for preparing the same

The present invention provides a film coated tablet comprising a first film coating layer comprising hydroxypropyl methylcellulose and a second film coating layer comprising polyvinyl alcohol, on a tablet containing choline alfoscerate as an active ingredient and magnesium aluminometasilicate as an additive; and a process for preparing the same.